Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Progesterone
Therapeutic Area : Ophthalmology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Signal12 Advances Pro-ocular™ to Phase 3 for Ocular GVHD
Details : Pro-ocular (progesterone) is a novel drop-free therapy poised to revolutionize the treatment of ocular Graft-versus-Host Disease (oGvHD).
Product Name : Pro-ocular
Product Type : Hormone
Upfront Cash : Inapplicable
March 18, 2025
Lead Product(s) : Progesterone
Therapeutic Area : Ophthalmology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable